55b63606-9c92-646b-abb7-a7685cd7844a

REPRIEVE@CROI 2022

The REPRIEVE Trial will present 6 abstracts (2 oral presentations, 4 poster presentations) at the Conference on Retroviruses and Opportunistic Infections (CROI) 2022. The conference will take place virtually from February 12-16. Please check back for dates and plans for results dissemination from REPRIEVE research. See below for full abstract listing.
Click here to read plain language summaries of our abstracts!

  • Monday, February 14, 2022 at 11:45 AM ESTOral Presentation: Activity Status by Global Burden of Disease Region in Adults with HIV at Low To Intermediate Risk of Cardiovascular Disease In The REPRIEVE Trial

    11:45 AM EST – 1:45 PM EST Presenting Author: Kristine Erlandson Session: MALIGNANCIES AND COMORBIDITIES: AN INCREASING BURDEN Type: Oral Presentation

  • Monday, February 14, 2022 at 11:45 AM ESTOral Presentation: COVID-19 Vaccination Rates in a Global HIV Cohort

    11:45 AM EST – 1:45 PM EST Presenting Author: Evelynne Fulda Session: EVOLVING EPIDEMIOLOGY OF HIV AND SARS-CoV-2 Type: Oral Presentation

  • Monday, February 14, 2022 at 4:00 PM ESTPoster Presentation: Hepatic Steatosis in People Living with HIV on Antiretroviral Therapy - Baseline Results from REPRIEVE

    4:00 PM EST – 5:30 PM EST Presenting Author: Carl Fichtenbaum Session: FATTY LIVER: NAFL, MAFL, AND NASH Type: Poster Presentation

  • Monday, February 14, 2022 at 4:00 PM ESTPoster Presentation: Sex-differences in Immune-mediated Subclinical Atherosclerosis Among ART-treated People with HIV Participating in The REPRIEVE Trial

    4:00 PM EST – 5:30 PM EST Presenting Author: Markella Zanni Session: RISK FACTOR AND INFLAMMATORY MEDIATORS OF CVD Type: Poster Presentation

  • Tuesday, February 15, 2022 at 3:30 PM ESTREPRIEVE Meeting at CROI 2022

    3:30 PM EST - 4:30 PM EST

  • Tuesday, February 15, 2022 at 4:00 PM ESTPoster Presentation: Asymptomatic SARS-COV-2 Infection Is Extremely Common Among People with HIV

    4:00 PM EST – 5:30 PM EST Presenting Author: Turner Overton Session: SARS-CoV-2 EPIDEMIOLOGY Type: Poster Presentation

  • Tuesday, February 15, 2022 at 4:00 PM ESTPoster Presentation: A Thorough Evaluation of Early Markers of Kidney Dysfunction (Albuminuria and Proteinuria) Among People with HIV from the REPRIEVE Trial Cohort

    4:00 PM EST – 5:30 PM EST Presenting Author: Turner Overton Session: OTHER COMORBIDITIES Type: Poster Presentation